What is Citizen Science anyway? Introduction to the new blog symposium “Citizen Science”

We are pleased to present this symposium featuring commentary from participants in the “Critical Studies of Citizen Science in Biomedical Research” conference held on the March 2, 2017, at King’s College London. Organized by different projects concerned with citizen science in Kiel (A. Buyx) & London (B. Prainsack), Exeter (S. Leonelli), and Geneva (B. Strasser),  the event took a critical look at the role of citizen science in biomedical research in the 21st Century. Presenters from the event give us a peek into their work in the forthcoming posts, which will appear daily. 

By Barbara Prainsack, Alena Buyx, and Amelia Fiske

As many of our teachers have told us, and as we have repeated told to our students: if you have to insist that you are engaging in a “critical” analysis, then something is wrong. We should be able to assume that as social scientists, ethicists, or scholars more generally we always take a critical distance to our materials. So why did we call a meeting on citizen science in biomedicine “critical studies of”?

The reason was one of emphasis: we wanted to bring together people who were not merely cheerleaders for citizen science, offering analyses that remove friction points in the name of making citizen science even better (whatever ‘better’ might mean in this respect). Instead, we were looking for work that challenges the very assumptions portraying citizen science as novel and noteworthy, or as something particularly problematic and in need of ethical attention. We did so not because we necessarily disagree with these portrayals, but because we felt that we should pay as much attention to continuities as to discontinuities; to old practices as well as to new ones; and to offline as well as online collaboration in scientific knowledge creation. We felt that only if we explored the values and goals underpinning practices and initiatives that use the label “citizen science” can we approach the questions that matter most to us: How do these practices change the distribution of power between different actors? Who is (dis)empowered by them? Who or what gains visibility, and who or what is obscured? What new patterns of inclusion or exclusion emerge as a result? We have long been interested in the concept of solidarity and its role in biomedicine (see our new book with Cambridge University Press), and we wanted to know if some of the citizen science initiatives could be seen as emerging forms of solidaristic practice. Read More

Health Law Rankings — Another Perspective

Glenn and Mark recently published a list of most-cited health law scholars, using the methods generally used for these studies in legal academia.  Like any academic who steadfastly denigrates the importance of lists, I naturally checked right away to see where I ranked, which was somewhere so far down the list that only an outbeak of smallpox at the AALS meeting could ever get me into the top twenty.  Since I was still completely uninterested in this whole ranking issue, my next move was to look at the methods.  And this is where I did have a thought worth sharing.

The source of the data is the JRL library on Westlaw, which I believe primarily covers law reviews and other legal publications.   How often one is cited in law reviews is certainly a good measure of impact within legal scholarsip, but it does not capture (or support) health law as an interdisciplinary field.  Indeed, I think it is arguable that for many of us, our most important impact will be on research and scholarship in other fields.  Does our top-twenty list look different if we draw on a broader database of citations?

I can’t tell you.  That would be a lot of work.  But there is a way to do it “collectively.”  Google tracks citations that appear anywhere in the googleverse and reports them in Google Scholar — if you create a profile. Most of the people in the top 20 in the Hall-Cohen top 20 do not have Google Scholar Profiles, but a few do and the results suggest we might see some differences in impact ranking if we went beyond law reviews:

Name Hall/Cohen cites (rank) Google cites (rank) since 2012
Larry Gostin 510 (1) 7150 (1)
I. Glenn Cohen 320 (4) 1143 (3)
Frank Paquale 300 (6) 1081 (4)
Lars Noah 280 (9) 586 (5)
David Studdert 190 (19) 7129 (2)

Everyone gets many more cites from Google than Westlaw, which reflects some methodological differences but also shows a lot of extra-legal impact.  Larry Gostin is still on top, by quite a distance, but David Studdert — at the bottom of the law review top 20 — comes near to catching him.  (I may as well admit that the Google ranking puts yours truly well above Cohen but nowhere near Studdent and Gostin.)

Why does this matter?  The obvious point is the one I have already made: health law scholars should be aiming to make a difference in health policy, and that is not measured by law review citations alone. For us to thrive as a field, we need more than ever to be engaged with non-lawyers, as my colleagues and I argue for public health law here. Recognizing non-legal citations is also, in my experience, extremely important for supporting young scholars.  If all we recognize and seem to value are law review citations, then junior scholars will only write law review articles. That is not how we build a field of engaged, cross-disciplinary scholars and researchers.  I encourage junior scholars to create Google Scholar profiles and I use them when I am doing promotion and tenure reviews in this list-mad age.

One last point: Google Scholar profiles take about two minutes to create and a very minimal effort to curate (if you care to, you need to eliminate some dupes and misatributions).  Whether you like rankings or transdisciplinary impact, you can help the field at minimal cost by signing up.

End of commercial.

Harvard Grad Students: Apply Now! Petrie-Flom Center Student Fellowship, 2017 – 2018

PFC_Logo_300x300The Center and Student Fellowship

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics is an interdisciplinary research program at Harvard Law School dedicated to the scholarly research of important issues at the intersection of law and health policy, including issues of health care financing and market regulation, biotechnology and intellectual property, biomedical research, and bioethics. The Student Fellowship Program is designed to support closely-mentored student research in these areas. For more information on our recent fellows and their work, see our website and check out profiles of some of our past Fellows in the PFC Spotlight.

Eligibility

The student fellowship program is open to all Harvard graduate students who will be enrolled at the University during the fellowship year and who are committed to undertaking a significant research project and fulfilling other program requirements. Although the fellowship is open to all graduate students, including those in one-year programs, we encourage those who are in multi-year programs to wait until after their first year to apply. Read More